Total Funding
70
15
Total FundingVenture - Series Unknown raised
Growth Score 70 in past quarter
-8 pts
Heat Score 15 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
655192
Owl biomedical develops microchip-based disposable cell sorting technology.
Acquired by 

Miltenyi Biotec
- Demetri Argyropoulos: Co-founder
About the Company
Owl biomedical, Inc. develops microchip-based disposable cell sorting technology for cell purification applications. Its technology is also used for basic stem cell and cancer cell research applications, and stem cell sorting for cosmetic and aesthetic markets. Owl biomedical, Inc. was formerly known as J2D BioMedical, Inc. The company was
incorporated in 2010 and is based in Santa Barbara, California. As of April 23, 2013, Owl biomedical, Inc. operates as a subsidiary of Miltenyi Biotec GmbH.


